Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including Nsclc, SCLC and Other Cancers
US 11,459,365 Lapsed on the fee recordLapsed Oct 4, 2026 on the fee record · High confidence
20-year base term ends Jul 3, 2038
First maintenance fee unpaid; grace period ended.
Jul 3, 2018
Oct 4, 2026
Oct 4, 2022
Jul 3, 2038
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jul 3, 2018, when the earliest non-provisional application in its chain was filed (this one was filed Feb 18, 2022) | Jul 3, 2038 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | lapsed Oct 4, 2026 | High confidence |
| Computed term end | The steps above, in order | Oct 4, 2026 | High confidence |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Not on this page: the patent's family, its recorded assignments and its citation count. USPTO's assignment records, linked above, list every recorded assignment.
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.